ELAN AND WARNER LAMBERT UNIT FORM JOINT VENTURE MARKETING COMPANY IN U.K.
ELAN AND WARNER LAMBERT UNIT FORM JOINT VENTURE MARKETING COMPANY IN U.K. ATHLONE, Ireland, July 16 /PRNewswire/ -- Elan Corporation PLC (AMEX: ELN) said today it reached agreement with Parke Davis UK (a unit of Warner Lambert (NYSE: WLA)) to form a joint venture to market a range of Elan-developed products in the U.K. The joint venture, to be called Elan Pharma Ltd., builds on the successful marketing collaboration between Elan and Parke Davis in Ireland. Donald E. Panoz, Elan's chairman and chief executive officer, said "We're delighted to further develop our relationship with Warner Lambert, this development is part of our mind to market strategy and provides a cost effective way for us to establish a profitable foothold in the $7 billion U.K. pharmaceutical market." Elan Corporation is a leader in the specialized health care field of advanced reformulation and drug delivery, concentrating on improved drug absorption and utilization. It operates research and manufacturing facilities in Athlone, Ireland; Gainesville, Ga.; Enschede, Netherlands; Manila, Philippines; Brea, Calif.; Cambridge, Mass.; and Mezzovico, Switzerland. -0- 7/16/92 /CONTACT: Brian Crotty of Elan, 800-252-3526; or Thomas Redington, 203-222-7399 or 212-926-1733, for Elan/ (ELN WLA) CO: Elan Corporation plc; Warner Lambert ST: New York IN: MTC SU:
SH-TS -- NY006 -- 9856 07/16/92 08:35 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 16, 1992|
|Previous Article:||AT&T REPORTS RECORD NET INCOME FOR QUARTER|
|Next Article:||ADVANCED VISUAL SYSTEMS, INTEL ANNOUNCE PLANS TO MAKE AVS AVAILABLE ON INTEL SUPERCOMPUTERS|